NASDAQ:RIGL

Rigel Pharmaceuticals Stock News

etoro logo Buy RIGL
*Your capital is at risk
$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026

Best Momentum Stock to Buy for August 8th

11:01am, Friday, 08'th Aug 2025
RIGL, APG and CLSK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 8, 2025.
LendingTree, RIGL, and others are standing out with strong relative price strength amid market volatility.

New Strong Buy Stocks for August 8th

07:10am, Friday, 08'th Aug 2025
INFU, RIGL, TROW, MITSY and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on August 8, 2025.
From a technical perspective, Rigel Pharmaceuticals, Inc. (RIGL) is looking like an interesting pick, as it just reached a key level of support. RIGL's 50-day simple moving average crossed above its 2
Rigel (RIGL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Rigel (RIGL) Q2 Revenue Jumps 176%

07:19am, Wednesday, 06'th Aug 2025
Rigel (RIGL) Q2 Revenue Jumps 176%
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants David A. Santos - Executive VP & Chief Commercial Officer Dean L.
Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $3.28 per share, beating the Zacks Consensus Estimate of $1.97 per share. This compares to a loss of $0.06 per share a year ago.
Second quarter 2025 total revenue of approximately $101.7 million, which includes net product sales of $58.9 million and contract revenues from collaborations of $42.7 million  Completed enrollment i
Rigel (RIGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The average of price targets set by Wall Street analysts indicates a potential upside of 69.6% in Rigel (RIGL). While the effectiveness of this highly sought-after metric is questionable, the positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
SOUTH SAN FRANCISCO, Calif. , July 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2025 financial results after market close
SOUTH SAN FRANCISCO, Calif. , July 7, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. I
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE